(Q34494637)

English

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial

scientific article

Statements

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial (English)
0 references
0 references
0 references
0 references
0 references
F Xavier Pi-Sunyer
Louis J Aronne
Hassan M Heshmati
Jeanne Devin
RIO-North America Study Group
1 February 2006

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit